SO
HUMA icon

STRS Ohio’s Humacyte HUMA Stock Holding History

STRS Ohio’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,100
Closed -$13K – 2039
2022
Q2 		$13K Buy
+4,100
New +$22.8K ﹤0.01% 1982

Other funds holding HUMA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

STRS Ohio's HUMA Position: Q3 2022 in Review

STRS Ohio sold out of Humacyte (HUMA) in Q3 2022, closing a stake of 4,100 shares — an estimated $13K sold.

STRS Ohio first reported a position in HUMA in Q2 2022 and held it in 1 quarter. The position peaked at $13K in Q2 2022. 70 funds tracked by Wall St. Rank hold HUMA as of Q3 2022.

  • STRS Ohio reported no remaining Humacyte position as of Q3 2022 after selling out during the quarter.
  • STRS Ohio sold 4,100 Humacyte shares in Q3 2022, an estimated $13K.
  • STRS Ohio first reported a position in Humacyte in Q2 2022 and held it in 1 quarter.
  • STRS Ohio's Humacyte position peaked at $13K in Q2 2022.
  • 70 funds tracked by Wall St. Rank held Humacyte as of Q3 2022.

Based on STRS Ohio's 13F filing for Q3 2022, filed 27 Oct 2022.